Sign up
Log in
BUZZ-Bristol Myers hits over four-year low after co swings to loss
Shares of drugmaker Bristol Myers Squibb fall 7.50% to hit over four-year low of $45.20. Co posts Q1 loss of $4.40/shr. Company slashes annual profit outlook due to charges related to recent acquisitions.
Reuters · 04/25 14:27
UPDATE 4-Bristol Myers posts quarterly loss, lays out $1.5 bln cost-saving plan
Bristol Myers Squibb posts quarterly loss, lays out $1.5 bln cost-saving plan. Charges related to acquisitions offset small increase in revenue, sending shares down 8%. The company also announced plans to save about $ 1.5 billion in costs by the end of 2025. Bristol's quarterly revenue rose 5% to $11.87 billion. Sales of older cancer drugs Opdivo and Revlimid fell.
Reuters · 04/25 11:45
BUZZ-Bristol Myers falls as deal costs weigh on 2024 outlook
Shares of drugmaker Bristol Myers Squibb fall 1.5% to $48.14 premarket. Co slashes annual profit outlook to between 40 cents and 70 cents per share due to deal costs. Company posts first-quarter loss of $4.40 per share. Sales of cancer drug Opdivo miss estimates by $24 million.
Reuters · 04/25 11:27
UPDATE 2-British billionaire Joe Lewis fined $5 million by US judge for insider trading
British billionaire Joe Lewis fined $5 million by US judge for insider trading. Lewis pleaded guilty in January to sharing illegal stock tips. The 87-year-old will serve three years of probation and pay a fine. Lewis is worth $6.2 billion, according to Forbes. Prosecutors said he passed on inside information on his portfolio companies.
Reuters · 04/04 19:49
Multibillionaire Joe Lewis to face US sentencing for insider trading
British multibillionaire Joe Lewis to face US sentencing for insider trading. Federal sentencing guidelines call for a prison sentence of up to two years. Prosecutors have urged leniency for the 87-year-old. Lewis admitted guilt in January to illegally sharing stock tips he gleaned from his investments.
Reuters · 04/04 15:31
Weekly Report: what happened at MRTX last week (0226-0301)?
Weekly Report · 03/04 09:14
Weekly Report: what happened at MRTX last week (0219-0223)?
Weekly Report · 02/26 09:16
Weekly Report: what happened at MRTX last week (0212-0216)?
Weekly Report · 02/19 09:16
Webull offers Mirati Therapeut stock information, including NASDAQ: MRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading MRTX stock methods without spending real money on the virtual paper trading platform.